Ebola Virus Disease (EVD) Laboratory Diagnostics · PDF fileEbola Virus Disease Laboratory...

23
Ebola Virus Disease (EVD) Laboratory Diagnostics Dr Joanne O’Gorman Deputy Director National Virus Reference Laboratory University College Dublin Ebola Conference 12.11.14 JOG

Transcript of Ebola Virus Disease (EVD) Laboratory Diagnostics · PDF fileEbola Virus Disease Laboratory...

Ebola Virus Disease (EVD)Laboratory Diagnostics

Dr Joanne O’GormanDeputy Director

National Virus Reference LaboratoryUniversity College Dublin

Ebola Conference 12.11.14 JOG

National Virus Reference Laboratory(NVRL)

• Located on campus in UCD

• Biosafety level 3 Facility(BSL-3)

• Member of ENIVD– European Network for Diagnostics

of “Imported” Viral Diseases

• Website http://nvrl.ucd.ie

Ebola Conference 12.11.14 JOG

Ebola Virus DiseaseLaboratory Criteria Case Defintion

Any of the following:

Isolation of Ebola virus from a clinical specimen.✖

Ebola Conference 12.11.14 JOG

Ebola Virus DiseaseLaboratory Criteria Case Defintion

Any of the following:

Isolation of Ebola virus from a clinical specimen.✖

Detection of Ebola virus nucleic acid in a clinicalspecimen and confirmation by sequencing or a

second assay on different genomic targets.✔

Ebola Conference 12.11.14 JOG

Testing Methodology

Zaire*SudanTai ForestBundibugyoRestonVirus*

Ebola Conference 12.11.14 JOG

RealStar RT-PCR [Altona] **

In house RT-PCRIn house RT-PCR

Testing Methodology

5mls

Ebola Conference 12.11.14 JOG

Requesting a test for EVD

Decision

Ebola Conference 12.11.14 JOG

Requesting a test for EVD

Sample Types EDTA & Serum (WCB)

Ebola Conference 12.11.14 JOG

Requesting a test for EVD

NVRL Contact Details Tel: 01 7164401Mob: 087 9806448

Ebola Conference 12.11.14 JOG

Requesting a test for EVD

Contact Details

Tel: 01 7164401Mob: 087 9806448

Ebola Conference 12.11.14 JOG

Packaging & TransportCategory A InfectiousSubstances• Category A infectious substances

are capable of causing permanentdisability, life threatening or fataldisease to humans or animalswhen exposure to them occurs.

• Category A infectious substanceshave two shipping names:“Infectious substances, Affectinghumans” (UN 2814) or“Infectious substances, affectinganimals” (UN 2900)

• Designated courier

Category A InfectiousSubstances• Category A infectious substances

are capable of causing permanentdisability, life threatening or fataldisease to humans or animalswhen exposure to them occurs.

• Category A infectious substanceshave two shipping names:“Infectious substances, Affectinghumans” (UN 2814) or“Infectious substances, affectinganimals” (UN 2900)

• Designated courier

Category B InfectiousSubstances

• Category B infectious substancesare infectious but do not meet thecriteria for Category A.

• Category B infectious substanceshave the proper shipping name“Biological Substance, CategoryB” and the identification numberUN 3373.

Ebola Conference 12.11.14 JOG

Transport of Biological Material:UN2814

Ebola Conference 12.11.14 JOG

Main corridor

BL3 laboratory-50Pa

ClassI/ IIIMSC

ClassIIIMSC

Shower-10Pa

Outer lobby

Inner lobby-35Pa

-20oC -80oCCO2Inc. 40C

+10Pa18 ac/h

Pass throughautoclave

Containment envelope

NVRL Testing Process – BSL 3

Ebola Conference 12.11.14 JOG

A. Security & accessB. Air handlingC. Dis-infection & disposal

proceduresD. Protective equipment &

procedures

Laboratory & StaffPreparation (2)

Laboratory & StaffPreparation (2)

Specimen Preparation& Centrifugation

Specimen Preparation& Centrifugation

RNA ExtractionGuanidine thiocyanate.

RNA ExtractionGuanidine thiocyanate.

PCRPCR

Result Interpretation &

CommunicationResult Interpretation &

Communication

B

S

L

3

B

S

L

3

B

S

L

2

B

S

L

2

Ebola Conference 12.11.14 JOG

Frequently Asked Questions

1. Turn Around Time ?

Ebola Conference 12.11.14 JOG

Frequently Asked Questions

1. Turn around time?

Most cases approx. 6 hours from receipt of samplein the NVRL.

Ebola Conference 12.11.14 JOG

Frequently Asked Questions

1 Turn Around Time?2 Sensitivity?

Ebola Conference 12.11.14 JOG

Frequently Asked Questions

1 Turn Around Time?2 Sensitivity?

– Assays• Performance & Proficiency Testing

– Sample• EDTA• Within 12 hours

– Patient• Decision to restest and timing of retesting based on exposure risk

assessment and clinical features

Ebola Conference 12.11.14 JOG

Frequently Asked Questions

1 Turn Around Time ?2 Sensitivity?3 Specificity?

Ebola Conference 12.11.14 JOG

Frequently Asked Questions

1 Turn Around Time ?2 Sensitivity?3 Specificity?

• Two assays with two different targets• 15 patients tested to date – ALL NEGATIVE

Ebola Conference 12.11.14 JOG

Key Messages

• Refer to the Ebola Virus Disease Risk AssessmentAlgorithm available @hpsc.ie

• Contact the NVRL prior to sending a sample.

• Results will be communicated to the designatedperson as soon as they are available ( approx 6hours)

Ebola Conference 12.11.14 JOG

Acknowledgements

• NVRL staff– Margaret Duffy– Grainne Tuite– Jeff Connell– Suzie Coughlan– Ger Franzoni– Brian Keogan

http://nvrl.ucd.ieEbola Conference 12.11.14 JOG

Ebola Conference 12.11.14 JOG